Toceranib 50mg
-
Catalog numberCS-0241-50mg
-
PricePlease ask
-
Size50mg
-
-
Alternative_NamesPHA 291639;SU11654
-
CAS356068-94-5
-
Purity>98%
-
MWt396.46
-
FormulaC22H25FN4O2
-
SolubilityDMSO : 2.5 mg/mL (6.31 mM; Need ultrasonic)
-
Clinical_InformationLaunched
-
PathwayProtein Tyrosine Kinase/RTK;Protein Tyrosine Kinase/RTK
-
TargetVEGFR;PDGFR
-
Gene target
-
Short nameToceranib 50mg
-
Alternative nameToceranib 50mg
-